Clinical Trial Update: Spironolactone for Hidradenitis Suppurativa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating spironolactone for hidradenitis suppurativa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Hidradenitis Suppurativa | Phase 4 | Status: WITHDRAWN